Application of liver biopsy in etiological diagnosis of unexplained portal hypertension: Porto-sinusoidal vascular disease should not be ignored

被引:0
作者
Zhang, Yu [1 ,2 ]
Liu, Hongli [1 ]
Xiong, Qingfang [2 ]
Zhong, Yandan [2 ]
Liu, Duxian [3 ]
Chen, Wei [4 ]
Yang, Yongfeng [2 ,5 ]
机构
[1] Southeast Univ, Dept Med, Nanjing, Peoples R China
[2] Nanjing Univ Chinese Med, Hosp Nanjing 2, Dept Infect & Liver Dis, Nanjing 210003, Peoples R China
[3] Nanjing Univ Chinese Med, Hosp Nanjing 2, Dept Pathol, Nanjing, Peoples R China
[4] Nanjing Univ Chinese Med, Hosp Nanjing 2, Clin Res Ctr, Nanjing, Peoples R China
[5] Clin Infect Dis Ctr Nanjing, Nanjing, Peoples R China
基金
中国国家自然科学基金;
关键词
cirrhosis; etiology; liver biopsy; portal hypertension; porto-sinusoidal vascular disease; CIRRHOSIS; HEPATITIS; FIBROSIS;
D O I
10.1097/MD.0000000000039819
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The diagnostic value of liver biopsy has been confirmed in patients with abnormal liver test results; however, little data are available on its application in patients with portal hypertension. This study aimed to investigate the utility of liver biopsy for the etiological diagnosis of unexplained portal hypertension, and explore the clinical and pathological characteristics of each etiology. A retrospective observational analysis was conducted on 1367 patients who underwent liver biopsy at the Second Hospital of Nanjing from 2017 to 2019. Of these, 188 patients with unexplained portal hypertension were enrolled. The clinical and pathological characteristics were collected and reassessed in a multidisciplinary team meeting. Among these patients, 174 (92.6%, 174/188) had a definite etiological diagnosis through liver biopsy. The main etiologies were autoimmune hepatitis in 47 patients (25%, 47/188), autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in 41 patients (21.8%, 41/188), and porto-sinusoidal vascular disease (PSVD) in 40 patients (21.3%, 40/188). Compared to liver cirrhosis, PSVD patients were younger and the liver function damage of which was subtler. The widths of portal vein diameter were widest in PSVD but the liver stiffness measurement were almost normal. Splenomegaly was common in PSVD, but ascites were less frequent than in autoimmune hepatitis (25.0% vs 51.1%, P = .013). Based on the histological patterns, we found that cholestatic liver diseases such as primary biliary cirrhosis, autoimmune hepatitis-primary biliary cirrhosis overlap syndrome, and progressive familial intrahepatic cholestasis could lead to non-cirrhotic portal hypertension, while vascular liver diseases such as PSVD and Budd-Chiari syndrome could also show fibrous proliferation as the disease progresses. Liver biopsy is safe and valuable for etiological diagnosis of unexplained portal hypertension. Cirrhosis is the leading cause of portal hypertension, and porto-sinusoidal vascular diseases should also be considered. Clinical features may be helpful in suggesting the cause; however, pathological examination is still indispensable for disease diagnosis and progression assessment.
引用
收藏
页数:8
相关论文
共 23 条
  • [1] The portal hypertension syndrome: etiology, classification, relevance, and animal models
    Bosch, Jaime
    Iwakiri, Yasuko
    [J]. HEPATOLOGY INTERNATIONAL, 2018, 12 : S1 - S10
  • [2] Cryptogenic cirrhosis: What are we missing?
    Caldwell S.
    [J]. Current Gastroenterology Reports, 2010, 12 (1) : 40 - 48
  • [3] The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
    Chalasani, Naga
    Younossi, Zobair
    Lavine, Joel E.
    Charlton, Michael
    Cusi, Kenneth
    Rinella, Mary
    Harrison, Stephen A.
    Brunt, Elizabeth M.
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2018, 67 (01) : 328 - 357
  • [4] Baveno VII - Renewing consensus in portal hypertension
    de Franchis, Roberto
    Bosch, Jaime
    Garcia-Tsao, Guadalupe
    Reiberger, Thomas
    Ripoll, Cristina
    [J]. JOURNAL OF HEPATOLOGY, 2022, 76 (04) : 959 - 974
  • [5] Porto-sinusoidal vascular disease: proposal and description of a novel entity
    de Gottardi, Andrea
    Rautou, Pierre-Emmanuel
    Schouten, Jeoffrey
    Rubbia-Brandt, Laura
    Leebeek, Frank
    Trebicka, Jonel
    Murad, Sarwa Darwish
    Vilgrain, Valerie
    Hernandez-Gea, Virginia
    Nery, Filipe
    Plessier, Aurelie
    Berzigotti, Annalisa
    Bioulac-Sage, Paulette
    Primignani, Massimo
    Seinela, David
    Elkrief, Laure
    Bedossa, Pierre
    Willa, Dominique
    Garcia-Pagan, Juan Carlos
    Jakob, Brigitte
    Cazals-Hatem, Dominique
    Alonso, Cristina
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (05) : 399 - 411
  • [6] Autoimmune hepatitis: Effect of symptoms and cirrhosis on natural history and outcome
    Feld, JJ
    Dinh, H
    Arenovich, T
    Marcus, VA
    Wanless, IR
    Heathcote, EJ
    [J]. HEPATOLOGY, 2005, 42 (01) : 53 - 62
  • [7] Causes and Management of Non-cirrhotic Portal Hypertension​
    Gioia S.
    Nardelli S.
    Ridola L.
    Riggio O.
    [J]. Current Gastroenterology Reports, 2020, 22 (12)
  • [8] He H., 2017, J Prac Hepatol, V20, P550
  • [9] Natural History of Cirrhosis: Changing Trends in Etiology Over the Years
    Idilman, Ramazan
    Aydogan, Merve
    Oruncu, Mehmet Berk
    Kartal, Aysun
    Elhan, Atilla Halil
    Ellik, Zeynep
    Gumussoy, Mesut
    Er, Ramazan
    Ozercan, Mubin
    Duman, Serkan
    Toruner, Murat
    Cinar, Kubilay
    Soykan, Irfan
    Beyler, Ali Resit
    Ozkan, Hasan
    [J]. DIGESTIVE DISEASES, 2021, 39 (04) : 358 - 365
  • [10] Explant liver evaluation decodes the mystery of cryptogenic cirrhosis!
    Jain, Mayank
    Venkataraman, Jayanthi
    Varghese, Joy
    Vij, Mukul
    Reddy, Mettu S.
    Rela, Mohamed
    [J]. JGH OPEN, 2020, 4 (01): : 39 - 43